Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Admescope provides preclinical and clinical-phase ADME-Tox contract research services to pharmaceutical, biotech, and veterinary companies. It specializes in drug metabolism, pharmacokinetics, drug-drug interactions, metabolite profiling/identification, quantitative bioanalysis, and related consulting. Since its acquisition by Symeres in 2020, it also offers integrated medicinal chemistry and broader drug discovery/development support via the parent organization. Admescope serves customers globally with tailored studies across all major therapeutic modalities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Admescope.